Onyx Biotec Ltd

NSE: ONYX

₹38.00

up-down-arrow-0.75 (-1.94%)

As on 11-Sep-2026IST

Market cap

info icon

₹69 Cr

Revenue (TTM)

info icon

₹62 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

1.2

Div. Yield

info icon

0 %

Onyx Biotec Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 38.00 High: 38.00

52 Week Range

Low: 24.20 High: 50.00

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹5 Cr

  • ROEROE information

    12.2 %

  • ROCEROCE information

    13.7 %

  • Industry P/EIndustry P/E information

    44.2

  • EV/EBITDAEV/EBITDA information

    18.9

  • Debt to EquityDebt to Equity information

    0.2

  • Book ValueBook Value information

    ₹30.7

  • EPSEPS information

    ₹2.7

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    18,132,200

Years Aggregate

CFO

₹--

EBITDA

₹--

Net Profit

₹--

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Onyx Biotec
-6.9 -17.4 -5.0 -21.2 -- -- --
BSE Healthcare
18.0 0.1 9.1 14.7 21.9 14.1 11.9
As on 11-Sep-2026
Company
2025
Onyx Biotec
-55.9
BSE Small Cap
-6.6
BSE Healthcare
-3.3

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Onyx Biotec
38.0 68.9 62.0 5.0 -- 12.2 -- 1.2
1,129.6 2,151.2 77.0 16.4 -- 43.4 64.3 19.9
97.1 35.4 56.3 -1.5 3.7 -4.9 -- 1.3
64.8 32.1 149.8 5.6 4.7 6.6 9.9 0.6
2,922.3 48,214.8 6,725.3 1,128.8 19.6 11.5 42.7 4.5
202.8 1,111.3 287.0 28.7 10.2 9.1 36 4.4
660.2 7,933.9 7,229.4 210.4 4.4 11 37.7 4.0
33.9 61.7 167.8 5.9 -- 5.7 -- 0.6
95.0 50.8 61.7 6.3 -- 28.9 7.1 1.6
140.6 52.7 21.2 3.2 21.4 19.1 16.3 2.8

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Onyx Biotec

--

  • Incorporated

    2005

  • Chairman

    --

  • Managing Director

    Sanjay Jain

  • Headquarters

    Solan, Himachal Pradesh

  • Website

    www.onyxbiotec.com

FAQs for Onyx Biotec

The share price of Onyx Biotec Ltd is ₹38.00 (NSE) as of 11-Sep-2026 IST. Onyx Biotec Ltd has given a return of -21.24% in the last 1 years.

Since, TTM earnings of Onyx Biotec Ltd is negative, P/E ratio is not available.
The P/B ratio of Onyx Biotec Ltd is 1.24 times as on 11-Sep-2026, a 58 discount to its peers’ median range of 2.96 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
21.23
1.89
2024
0.00
0.00
2023
0.00
0.00
2022
0.00
0.00
2025
21.23
1.89

The 52-week high and low of Onyx Biotec Ltd are Rs 50.00 and Rs 24.20 as of 14-Sep-2026.

Onyx Biotec Ltd has a market capitalisation of ₹ 69 Cr as on 11-Sep-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Onyx Biotec Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...